Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals
(IRWD)
Ironwood Pharmaceuticals, Inc is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Duzallo
Lesinurad
,
Allopurinol
2017-08-18
2025-2032
Hyperuricemia
,
Gout
Zurampic
Lesinurad
2015-12-22
2025-2032
Hyperuricemia
,
Gout
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lesinurad
chronic renal insufficiency
,
kidney diseases
,
gout
Allopurinol
chronic renal insufficiency
,
kidney diseases
,
gout
Enoblituzumab
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
RECANACLOTIDE
gastroparesis
,
gastrointestinal diseases
,
dyspepsia
,
digestive system diseases
Bos taurus adrenal cortex corticosteroids
radiculopathy
Maltodextrin
osteoporosis
,
postmenopausal osteoporosis
,
migraine disorders
,
headache
,
post-traumatic headache
Antineoplaston a10
lymphoma
,
leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
myeloid leukemia
,
blast crisis
,
breast neoplasms
,
pancreatic neoplasms
,
head and neck neoplasms
,
lung neoplasms
,
sarcoma
,
bile duct neoplasms
,
liver neoplasms
,
colonic neoplasms
,
squamous cell carcinoma
,
cholangiocarcinoma
,
squamous cell neoplasms
,
chordoma
,
t-cell lymphoma
,
t-cell lymphoma peripheral
Replens
bacterial conjunctivitis
,
conjunctivitis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use